Home
Conditions
Neoplasms, Nerve Tissue

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,301 public trials 1,292 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Completed

AMG 595 First-in-Human in Recurrent Gliomas

NCT01475006

Conditions: Advanced Malignant Glioma, Anaplastic Astrocytomas, Astrocytoma, +17 more
Locations: Research Site Los Angeles, California, United States

Research Site Boston, Massachusetts, United States

Research Site Cincinnati, Ohio, United States

Research Site Parkville, Victoria, Australia

View Trial Details

Completed

Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

NCT01673009

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +11 more
Locations: Indiana University Indianapolis, Indiana, United States

View Trial Details

Completed

Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery

NCT02234297

Conditions: Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: Cedars-Sinai Medical Center Los Angeles, California, United States

NEWRO Foundation Brisbane, Queensland, Australia

View Trial Details

Completed

Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI

NCT01425749

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma

NCT00004104

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Kaplan Cancer Center New York, United States

View Trial Details

Completed

Impact of Excision Margins on Survival and Recurrence Rate in Patients With Thick Melanoma (>2mm)

NCT02088762

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Department of Dermatology Bern, Switzerland

View Trial Details

Completed

RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation

NCT01317615

Conditions: Carcinoma, Carcinoma, Large Cell, Lung Diseases, +12 more
Locations: Novartis Investigative Site Berlin, Germany

Novartis Investigative Site Bremen, Germany

Novartis Investigative Site Cologne, Germany

Novartis Investigative Site Essen, Germany

View Trial Details

Completed

68Ga-DOTATATE PET Scan in Neuroendocrine Cancer

NCT01396382

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +19 more
Locations: Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Completed

A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas

NCT00995007

Conditions: Anaplastic Astrocytoma, Anaplastic Mixed Oligoastrocytoma, Anaplastic Oligodendroglioma, +24 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Comparison of In-House Methods and Cobas BRAF V600 Mutation Assay in Melanoma Tumor Samples

NCT01744860

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Boulogne-Billancourt, France

Colmar, France

Lille, France

Lyon, France

View Trial Details

Neoplasms, Nerve Tissue

Neoplasms, Nerve Tissue trial results

Related conditions